Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

  title={Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain},
  author={Tina O'Donnell and Susan Rotzinger and Thomas T. Nakashima and Christopher C. Hanstock and Michele Ulrich and Peter H. Silverstone},
  journal={Brain Research},

Figures and Tables from this paper

Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol

The main finding is that contrary to lithium, the anticonvulsants and antidepressants used to treat bipolar disorder do not alter brain myo-inositol concentration, which suggests that these agents might work via a mechanism that is not centered on changes in myo, inositol concentrations.

Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients

It is unlikely that either lithium or valproate produce clinically relevant changes in myo-inositol concentrations or the PI-cycle, and given the current technical and clinical limitations of the literature to date, this conclusion cannot be considered completely definitive.

Valproate decreases inositol biosynthesis

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients

The results support suggestions that longer-term administration of lithium to bipolar patients may increase NAA concentrations and suggest that chronic administration of sodium valproate to patients does not lead to similar changes in NAA concentration.

Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T

A significant reduction exists in myo-inositol concentrations in lithium-treated rats at 2 and 4 weeks, across all four brain regions, suggesting that lithium-induced reduction of myo, inositol is more global than previously thought.

Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.

This study does not support the involvement of intraplatelet [Ca2+] in the dextroamphetamine model of mania; however, the modulation of intra platelet [ Ca2+) by the mood stabilizers lithium chloride, sodium valproate and carbamazepine implicates intracellular [Ca1+]In the therapeutic mechanisms of these drugs and the pathophysiological basis of manIA.

Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.

Overall, in bipolar patients who are manic or depressed there are abnormalities in brain myo-inositol concentrations, with changes in frontal and temporal lobes, as well as the cingulate gyrus and basal ganglia.



Lithium Effects on Inositol Phospholipids and Inositol Phosphates: Evaluation of an In Vivo Model for Assessing Polyphosphoinositide Turnover in Brain

The suitable use of the radiotracer technique together with lithium administration for assessing the effects of drugs and receptor agonists on the signaling system involving polyphosphoinositide turnover in brain is demonstrated.

The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates.

  • J. F. DixonL. Hokin
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1997
Valproic acid behaves similarly to lithium in that at therapeutic concentrations it stimulates glutamate release and Ins(1,4,5)P3 accumulation in mouse cerebral cortex slices, and is additional evidence against the "inositol depletion" hypothesis.

Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.

Valproate induces a concentration- and time-dependent reduction of MARCKS in immortalized hippocampal cells that appears to be independent of both the level of muscarinic receptor-activated PI signaling as well as the concentration of myo-inositol.

Evidence that Lithium Alters Phosphoinositide Metabolism: Chronic Administration Elevates Primarily d‐myo‐Inositol‐1‐Phosphate in Cerebral Cortex of the Rat

Data are presented showing that lithium is an uncompetitive inhibitor of the hydrolysis of both d‐ and l‐M1P by M1P’ase, and evidence that Lithium is largely producing this effect via phospholipase C‐mediated phosphoinositide metabolism is presented.

Cerebral lithium, inositol and inositol monophosphates.

  • M. Hirvonen
  • Biology, Medicine
    Pharmacology & toxicology
  • 1991
Lithium-induced accumulation of Ins1P or changes of Ins4P levels do not explain lithium-induced decrease in cerebral inositol, and effects of lithium on brain P1 turnover are likely to be multifocal and to differ markedly at different concentrations of Li+ in the brain.

Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus

It is concluded that chronic lithium treatment at therapeutically relevant brain concentrations does not evoke major changes in the inositol content of the brain but induces a moderate decrease which is restricted to the hypothalamus.